As a type 1 diabetic I'm super excited to see apple working in this space, even if they're focusing it on type 2 to start (a logical move, considering there is something like 30x more type 2 diabetics in the US). I think making it easier to track glucose levels in real time is the number one thing that can be done to improve quality of life for
both types of diabetics.
The "CGM" (continuous glucose monitor) has really come into it's own over the last 10 or so years, and I would encourage all diabetics (but especially type 1) to use one. Currently the only 2 real options on the market are:
- http://www.dexcom.com/ - Connects directly to your phone using bluetooth and will send glucose warnings etc as notifications.
- https://www.medtronicdiabetes.com/products/enlite-sensor - Designed to work with Medtronic (who is a market leader) insulin pumps.
Both these options are expensive (even with insurance for many), invasive, and not really tailored towards "casual" glucose monitoring. I think if Apple enters the space with a non-invasive tool it'll be a huge boon for causal glucose monitoring. I also think it could be a more accessible option for people who are interested using a CGM to treat their diabetes but can't/won't use one of the existing options due to cost or inconvenience.
This seems like a win win and I'm excited to see where it goes.
The "CGM" (continuous glucose monitor) has really come into it's own over the last 10 or so years, and I would encourage all diabetics (but especially type 1) to use one. Currently the only 2 real options on the market are:
- http://www.dexcom.com/ - Connects directly to your phone using bluetooth and will send glucose warnings etc as notifications.
- https://www.medtronicdiabetes.com/products/enlite-sensor - Designed to work with Medtronic (who is a market leader) insulin pumps.
Both these options are expensive (even with insurance for many), invasive, and not really tailored towards "casual" glucose monitoring. I think if Apple enters the space with a non-invasive tool it'll be a huge boon for causal glucose monitoring. I also think it could be a more accessible option for people who are interested using a CGM to treat their diabetes but can't/won't use one of the existing options due to cost or inconvenience.
This seems like a win win and I'm excited to see where it goes.